vs
Side-by-side financial comparison of ESCO TECHNOLOGIES INC (ESE) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $289.7M, roughly 1.0× ESCO TECHNOLOGIES INC). Bio-Techne runs the higher net margin — 12.8% vs 9.9%, a 2.9% gap on every dollar of revenue. On growth, ESCO TECHNOLOGIES INC posted the faster year-over-year revenue change (17.3% vs -6.4%). Over the past eight quarters, ESCO TECHNOLOGIES INC's revenue compounded faster (7.8% CAGR vs 4.2%).
Esco is a Singaporean brand that develops, manufactures, and sells products and services for laboratories.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
ESE vs TECH — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $289.7M | $295.9M |
| Net Profit | $28.7M | $38.0M |
| Gross Margin | 41.4% | 64.6% |
| Operating Margin | 13.2% | 18.4% |
| Net Margin | 9.9% | 12.8% |
| Revenue YoY | 17.3% | -6.4% |
| Net Profit YoY | 22.2% | 68.3% |
| EPS (diluted) | $1.11 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $289.7M | $295.9M | ||
| Q3 25 | $286.5M | — | ||
| Q2 25 | $296.3M | $317.0M | ||
| Q1 25 | $265.5M | $316.2M | ||
| Q4 24 | $247.0M | $297.0M | ||
| Q3 24 | $298.5M | $289.5M | ||
| Q2 24 | $260.8M | $306.1M | ||
| Q1 24 | $249.1M | $303.4M |
| Q4 25 | $28.7M | $38.0M | ||
| Q3 25 | $218.7M | — | ||
| Q2 25 | $26.1M | $-17.7M | ||
| Q1 25 | $31.0M | $22.6M | ||
| Q4 24 | $23.5M | $34.9M | ||
| Q3 24 | $34.3M | $33.6M | ||
| Q2 24 | $29.2M | $40.6M | ||
| Q1 24 | $23.2M | $49.1M |
| Q4 25 | 41.4% | 64.6% | ||
| Q3 25 | 45.9% | — | ||
| Q2 25 | 41.2% | 62.7% | ||
| Q1 25 | 41.1% | 67.9% | ||
| Q4 24 | 39.8% | 65.3% | ||
| Q3 24 | 40.1% | 63.2% | ||
| Q2 24 | 39.6% | 66.4% | ||
| Q1 24 | 38.8% | 67.4% |
| Q4 25 | 13.2% | 18.4% | ||
| Q3 25 | 17.2% | — | ||
| Q2 25 | 11.2% | -7.5% | ||
| Q1 25 | 15.3% | 12.2% | ||
| Q4 24 | 11.4% | 16.0% | ||
| Q3 24 | 14.8% | 13.8% | ||
| Q2 24 | 14.3% | 15.0% | ||
| Q1 24 | 11.7% | 22.1% |
| Q4 25 | 9.9% | 12.8% | ||
| Q3 25 | 76.3% | — | ||
| Q2 25 | 8.8% | -5.6% | ||
| Q1 25 | 11.7% | 7.1% | ||
| Q4 24 | 9.5% | 11.7% | ||
| Q3 24 | 11.5% | 11.6% | ||
| Q2 24 | 11.2% | 13.3% | ||
| Q1 24 | 9.3% | 16.2% |
| Q4 25 | $1.11 | $0.24 | ||
| Q3 25 | $8.43 | — | ||
| Q2 25 | $1.01 | $-0.11 | ||
| Q1 25 | $1.20 | $0.14 | ||
| Q4 24 | $0.91 | $0.22 | ||
| Q3 24 | $1.32 | $0.21 | ||
| Q2 24 | $1.13 | $0.26 | ||
| Q1 24 | $0.90 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $103.8M | $172.9M |
| Total DebtLower is stronger | $145.5M | $260.0M |
| Stockholders' EquityBook value | $1.6B | $2.0B |
| Total Assets | $2.4B | $2.5B |
| Debt / EquityLower = less leverage | 0.09× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $103.8M | $172.9M | ||
| Q3 25 | $101.3M | — | ||
| Q2 25 | $78.7M | $162.2M | ||
| Q1 25 | $57.4M | $140.7M | ||
| Q4 24 | $71.3M | $177.5M | ||
| Q3 24 | $66.0M | $187.5M | ||
| Q2 24 | $63.0M | $152.9M | ||
| Q1 24 | $59.4M | $145.3M |
| Q4 25 | $145.5M | $260.0M | ||
| Q3 25 | $186.0M | — | ||
| Q2 25 | $525.0M | $346.0M | ||
| Q1 25 | $88.0M | $330.0M | ||
| Q4 24 | $112.0M | $300.0M | ||
| Q3 24 | $122.0M | $300.0M | ||
| Q2 24 | $173.0M | $319.0M | ||
| Q1 24 | $191.0M | $389.0M |
| Q4 25 | $1.6B | $2.0B | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.3B | $1.9B | ||
| Q1 25 | $1.3B | $2.0B | ||
| Q4 24 | $1.2B | $2.1B | ||
| Q3 24 | $1.2B | $2.1B | ||
| Q2 24 | $1.2B | $2.1B | ||
| Q1 24 | $1.2B | $2.0B |
| Q4 25 | $2.4B | $2.5B | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.5B | $2.6B | ||
| Q1 25 | $1.8B | $2.6B | ||
| Q4 24 | $1.8B | $2.7B | ||
| Q3 24 | $1.8B | $2.7B | ||
| Q2 24 | $1.8B | $2.7B | ||
| Q1 24 | $1.8B | $2.7B |
| Q4 25 | 0.09× | 0.13× | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.40× | 0.18× | ||
| Q1 25 | 0.07× | 0.16× | ||
| Q4 24 | 0.09× | 0.14× | ||
| Q3 24 | 0.10× | 0.14× | ||
| Q2 24 | 0.14× | 0.15× | ||
| Q1 24 | 0.16× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $68.9M | — |
| Free Cash FlowOCF − Capex | $63.0M | — |
| FCF MarginFCF / Revenue | 21.7% | — |
| Capex IntensityCapex / Revenue | 2.0% | — |
| Cash ConversionOCF / Net Profit | 2.40× | — |
| TTM Free Cash FlowTrailing 4 quarters | $239.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $68.9M | — | ||
| Q3 25 | $109.9M | — | ||
| Q2 25 | $73.7M | $98.2M | ||
| Q1 25 | $24.1M | $41.1M | ||
| Q4 24 | $34.2M | $84.3M | ||
| Q3 24 | $72.1M | $63.9M | ||
| Q2 24 | $36.2M | $75.5M | ||
| Q1 24 | $10.5M | $81.0M |
| Q4 25 | $63.0M | — | ||
| Q3 25 | $97.8M | — | ||
| Q2 25 | $64.9M | $93.3M | ||
| Q1 25 | $14.0M | $31.0M | ||
| Q4 24 | $29.0M | $77.5M | ||
| Q3 24 | $60.9M | $54.7M | ||
| Q2 24 | $27.6M | $57.5M | ||
| Q1 24 | $2.0M | $64.5M |
| Q4 25 | 21.7% | — | ||
| Q3 25 | 34.1% | — | ||
| Q2 25 | 21.9% | 29.4% | ||
| Q1 25 | 5.3% | 9.8% | ||
| Q4 24 | 11.7% | 26.1% | ||
| Q3 24 | 20.4% | 18.9% | ||
| Q2 24 | 10.6% | 18.8% | ||
| Q1 24 | 0.8% | 21.3% |
| Q4 25 | 2.0% | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 3.0% | 1.5% | ||
| Q1 25 | 3.8% | 3.2% | ||
| Q4 24 | 2.1% | 2.3% | ||
| Q3 24 | 3.8% | 3.2% | ||
| Q2 24 | 3.3% | 5.9% | ||
| Q1 24 | 3.4% | 5.4% |
| Q4 25 | 2.40× | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | 2.83× | — | ||
| Q1 25 | 0.78× | 1.82× | ||
| Q4 24 | 1.46× | 2.42× | ||
| Q3 24 | 2.10× | 1.90× | ||
| Q2 24 | 1.24× | 1.86× | ||
| Q1 24 | 0.45× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESE
| US Government | $98.0M | 34% |
| Utility Solutions Group | $87.5M | 30% |
| RF Shielding And Test | $58.3M | 20% |
| Commercial | $45.8M | 16% |
| Related Party | $1.3M | 0% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
